C. Fuchs

1. Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days
   2017/06/22 by Christian Fuchs, C. Fuchs, S. Wauschkuhn +17 · 20 citations
   Medicine · Immunology and Microbiology · #Sepsis Diagnosis and Treatment #Immune Response and Inflammation #Cardiac, Anesthesia and Surgical Outcomes